Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin vs fluvastatin + ezetimibe in patients with coronary heart disease or CHD equivalent
2004-002535-12Phase 3Completed
- Sponsor
- Clinical Institute of Medical and Chemical Laboratory Diagnostics
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fluvastatin and ezetimibe in hypercholesterolemia, coronary arteriosclerosis and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Clinical Institute of Medical and Chemical Laboratory Diagnostics. Primary endpoint: Low density lipoprotein cholesterol (LDL-C). Started Oct 2004; status: completed.
02
Drugs
fluvastatinezetimibe
03
Conditions
hypercholesterolemiacoronary arteriosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2004-002535-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002535-12.